Beiersdorf and Rubedo Life Science have entered into a strategic partnership. They reportedly want to jointly develop an anti-ageing solution for the global facial care market. The German skincare group will utilise the US company's expertise in combating cellular senescence. The partnership will focus on research into novel active ingredients that originate from the new partner's research programmes. These are said to be primarily anti-inflammatory and senolytic agents. Beiersdorf will also support Rubedo as an investor in future. Further information …